Genenta Science S.p.A (GNTA) Current Assets (2020 - 2025)
Genenta Science S.p.A (GNTA) posted Current Assets of $34.9 million for Q4 2025, up 46.84% sequentially from $23.8 million in Q2 2025, and up 125.64% YoY from $15.5 million in Q4 2024.
Genenta Science S.p.A (GNTA) Current Assets (2020 - 2025) Analysis & Trends
Genenta Science S.p.A has reported Current Assets for 6 years, with the latest figure at $34.9 million in Q4 2025.
- Quarterly Current Assets rose 125.64% year-over-year to $34.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34.9 million (up 125.64% YoY) and the FY2025 annual result came in at $34.9 million, up 125.64% from the prior year.
- Current Assets improved to $34.9 million in Q4 2025 per GNTA's latest filing, from $23.8 million in the prior quarter.
- Over five years, Current Assets peaked at $44.3 million in Q4 2021 and troughed at $15.5 million in Q4 2024.
- A 5-year average of $28.9 million and a median of $26.7 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2025: Current Assets sank 33.12% in 2023, then jumped 125.64% in 2025.
- Over 5 years, Current Assets stood at $44.3 million in 2021, then declined by 27.01% to $32.4 million in 2022, then fell by 29.33% to $22.9 million in 2023, then slumped by 32.38% to $15.5 million in 2024, then soared by 125.64% to $34.9 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $34.9 million, $23.8 million, and $15.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 1.76 Bn |
| 10 | Genenta Science S.p.A | 24.83 Mn | -34.26 Mn | - | 34.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.90 Mn |
| Jun 30, 2025 | 23.77 Mn |
| Dec 31, 2024 | 15.47 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Dec 31, 2023 | 22.87 Mn |
| Jun 30, 2023 | 26.70 Mn |
| Dec 31, 2022 | 32.36 Mn |
| Jun 30, 2022 | 39.92 Mn |
| Dec 31, 2021 | 44.34 Mn |
| Dec 31, 2020 | 19.71 Mn |